Articles From: Alkermes Announces Positive Results of Phase 2 Clinical Trial of ALKS 3831 in Schizophrenia to Alleghany Corporation To Announce 2014 Fourth Quarter And Full Year Results On February 24, 2015


2015/1/7
Alkermes plc (NASDAQ: ALKS) today announced positive topline results from the 12-week, randomized, double-blind, active-controlled, dose-ranging stage of a phase 2 study of ALKS 3831, an investigational, novel, oral atypical antipsychotic drug candidate designed to be a broad-spectrum treatment for schizophrenia.
Sign-up for Alkermes Announces Positive Results of Phase 2 Clinical Trial of ALKS 3831 in Schizophrenia investment picks
2015/2/9
Alkermes plc (NASDAQ: ALKS) today announced positive topline results from a phase 1, randomized, double-blind clinical study of ALKS 8700, a novel monomethyl fumarate (MMF) molecule in development for the treatment of multiple sclerosis (MS). ALKS 8700 is designed to rapidly and efficiently convert to MMF in the body and offer differentiated features as compared to the currently marketed dimethyl fumarate, TECFIDERA ® .
Sign-up for Alkermes Announces Positive Topline Results From Phase 1 Study of ALKS 8700 for Treatment of Multiple Sclerosis investment picks
2015/2/24
Alkermes plc (NASDAQ: ALKS) today announced topline results from a phase 1 clinical study of ALKS 7106, a new molecule intended for the treatment of pain.
Sign-up for Alkermes Announces Results From Phase 1 Study of ALKS 7106 investment picks
2015/2/23
Alkermes plc (NASDAQ: ALKS) announced today that it will webcast its Analyst and Investor Event presentation on Monday, March 2, 2015.
Sign-up for Alkermes Announces Webcast of Analyst and Investor Event on March 2, 2015 investment picks
2015/2/23
Alkermes plc (NASDAQ: ALKS) today announced that it has appointed Mark Namchuk, Ph.D., as Senior Vice President of Research, Pharmaceutical and Nonclinical Development.
Sign-up for Alkermes Appoints Mark Namchuk, Ph.D., As Senior Vice President of Research, Pharmaceutical and Nonclinical Development investment picks
2015/2/24
Alkermes plc (NASDAQ: ALKS) today reported financial results for the twelve months ended Dec.
Sign-up for Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2014 and Provides Financial Expectations for 2015 investment picks
2015/1/7
Alkermes Plc shares (ALKS) rose 5% in premarket trade Wednesday, after the company announced positive results from a Phase 2 clinical trial of a treatment for schizophrenia.
Sign-up for Alkermes shares up 5% on news of positive trial for schizophrenia drug investment picks
2015/2/17
Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EST (1:30 p.m. GMT) on Tuesday, Feb.
Sign-up for Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2014 Financial Results investment picks
2015/1/6
Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the 33 rd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan.
Sign-up for Alkermes’ Corporate Presentation to be Webcast at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/2/24
Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Cowen and Company 35 th Annual Health Care Conference on Tuesday, March 3, 2015, at 10:40 a.m. EST (3:40 p.m. GMT) from The Boston Marriott Copley Place in Boston.
Sign-up for Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 35th Annual Health Care Conference investment picks
2015/2/3
Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the 17 th Annual BIO CEO & Investor Conference on Tuesday, Feb.
Sign-up for Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences investment picks
2015/1/14
The SPDR Dow Jones Industrial Average ETF (DIA) slumped 1.4% in premarket trade Wednesday, as all 30 Dow components were on track to suffer losses at the open.
Sign-up for All 30 Dow stocks are falling in premarket trade investment picks
2015/2/10
ExOne's Troy, Mich.
Sign-up for All Five ExOne North American Production Service Centers Now Certified for ISO 9001:2008 investment picks
2015/2/9
-Extended Follow-Up Shows 4/14 Patients Treated with a Single SC Dose of 2 mg/kg of RG-101 are Target Not Detected at Day 85 - - Study Enrolled HCV Patients with Multiple Genotypes, Liver Fibrosis Status and Prior Treatment History - - Conference Call Today at 8:00 a.m. EST to Discuss Results - LA JOLLA, Calif.
Sign-up for All HCV Patients Treated with a Single SC Administration of 4 mg/kg of RG-101 Responded with Mean Viral Load Reduction of 4.8 log10 at Day 29 and 9/14 Patients are Below the Limit of Quantification at Day 57 investment picks
2014/12/11
Premium entertainment network EPIX and the National Hockey League announced today that film director, author, and avid hockey fan Kevin Smith (Tusk , Clerks ) will host weekly recaps of the EPIX Original Series EPIX Presents Road To The NHL Winter Classic™ and EPIX Presents Road To The NHL Stadium Series™ , produced by 52-time Emmy® Award winner Ross Greenburg.
Sign-up for All Roads Lead to EPIX This Winter investment picks
2015/1/12
Ford, America’s truck leader, today introduced the all-new F-150 Raptor – the ultimate high-performance off-road pickup in the company’s lineup.
Sign-up for All-New F-150 Raptor Is Ford’s Toughest, Smartest, Most Capable Truck for Ultimate Off-Road Performance investment picks
2015/1/12
The 2015 Ford F-150 took home the North American Truck of the Year award today.
Sign-up for All-New Ford F-150 Named North American Truck/Utility of the Year investment picks
2015/2/3
Ford today revealed the all-new Focus RS, a high-performance road car that debuts Ford Performance All-Wheel Drive with Dynamic Torque Vectoring Control, which contributes to performance never before seen in a Focus RS.
Sign-up for All-New Ford Focus RS; High-Performance Hatch with Innovative All-Wheel Drive Set for U.S. Debut investment picks
2015/1/13
The all-new Lincoln MKX, debuting today at the 2015 North American International Auto Show, is designed to attract a wide range of customers in the United States and beyond by offering more technology, engine choices and personalization options.
Sign-up for All-New Lincoln MKX Delivers Personal Luxury to Attract New Global Customers investment picks
2015/2/5
Get ready to soak up the sun in our bigger, wetter water park this summer DOSWELL, Va.
Sign-up for All-New Soak City Water Park to Replace WaterWorks at Kings Dominion investment picks
2015/1/20
http://www.ccnmatthews.com/logos/20100122-allana200.jpg TORONTO, ONTARIO --
Sign-up for Allana Potash Corp. Announces Election of Directors investment picks
2015/2/24
Allbanc Split Corp.
Sign-up for Allbanc Split Corp. Announces Partial Call for Redemption investment picks
2015/2/19
AllBanc Split Corp.
Sign-up for AllBanc Split Corp. Declares Quarterly Dividends investment picks
2015/2/11
Allbanc Split Corp.
Sign-up for Allbanc Split Corp. II Declares Quarterly Dividends investment picks
2015/2/11
Allbanc Split Corp.
Sign-up for Allbanc Split Corp. II Partial Call for Redemption investment picks
2015/1/26
IRVINE, Calif., Jan.
Sign-up for AllDigital Announces Global Launch of AllDigital Brevity Software investment picks
2015/2/19
IRVINE, Calif., Feb.
Sign-up for AllDigital Helps GVTV Speed High Definition Video to the Cloud investment picks
2015/2/24
NEW YORK , Feb.
Sign-up for Alleghany Corporation Reports 2014 Fourth Quarter And Full Year Results -- Notice investment picks
2015/1/28
NEW YORK , Jan.
Sign-up for Alleghany Corporation To Announce 2014 Fourth Quarter And Full Year Results On February 24, 2015 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Alkermes Announces Positive Results of Phase 2 Clinical Trial of ALKS 3831 in Schizophrenia to Alleghany Corporation To Announce 2014 Fourth Quarter And Full Year Results On February 24, 2015
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent